Surrey Heartlands

Joint Formulary & PAD

Roxadustat - Anaemia

You are here : Home > Formulary Search > Roxadustat - Anaemia

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
ICB
NICE
SPC
Restrictions / Comments :

Documentation

Evidence Review
Roxadustat for Anaemia in Chronic Kidney Disease - NICE briefing paper - October 2022.
Webpage
NICE TA807 -Roxadustat for Anaemia in Chronic Kidney Disease - NICE brieing paper - July 2022

PAD Profile

ChemicalSubstance :
Roxadustat
Indication :
Anaemia
Group Name :
Keywords :
dialysis-induced anaemia, CKD, chronic kidney disease
Brand Names Include :
Evrenzo
Important Information :

Renal specialist teams only.

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
2

Other Indications

Below are listed other indications that Roxadustat is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Anaemia.

Committee Recommendations (1)

05 Oct 22 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Integrated Care System Area Prescribing Committee (APC) has agreed the use of Roxadustat for treating symptomatic anaemia in chronic kidney disease in line with NICE TA807

Roxadustat will be given a RED traffic light status. Prescribing will be by hospital specialists only, in line with NICE TA807. 

Primary care prescribers should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient's medication.